3 news items
Catheter Precision, Inc. (NYSE: VTAK) Announces Initial Orders from Ronald Reagan UCLA Medical Center and Rady Children's Hospital in San Diego for LockeT
VTAK
13 May 24
that the hospital and its staff see the value and benefits that LockeT can bring and expectations regarding LockeT evaluations in the coming weeks
Catheter Precision, Inc. (NYSE American: VTAK) Announces the First use of LockeT Outside of the United States
VTAK
11 Mar 24
was quick to observe that LockeT is not only simple in design, but simple to use and that it effectively creates hemostasis and provides additional benefits
Catheter Precision, Inc. (NYSE American:VTAK) Announces the First Use of VIVO With a Pediatric Patient in Turkey
VTAK
28 Feb 24
this continues to show the flexibility and many benefits of this innovative product."About VIVOCatheter Precision's VIVO
- Prev
- 1
- Next